IIQ are due to launch their breast cancer 'lab test' in just a few weeks. I wanted to start this thread to better understand exactly what to expect from this point on. And welcome any thoughts. A few questions: Does a lab test directly imply commercial sales? If so, how are these executed - initially? eg a limited number of labs delivering breast cancer blood tests to paying customers? Or maybe subsidised tests for a cohort of customers? How does FDA approval fit into this? How does production of the chemicals fit into this? Where will this start? Australia? US?... How much revenue could be earned in first quarter? first year? ... What are the key impediments to success? Are the current specificity and sensitivity results sufficient to enable success - or is much more needed? And so on... Look forward to a great discussion
IIQ Price at posting:
62.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)